Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT03891446 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03891446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03891446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
March 27, 2019
Completion date
June 19, 2026
Enrollment
455 (actual)
Sites
124

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma